Home/Filings/4/0001209191-20-055424
4//SEC Filing

Horowitz Limited Partnership VIII 4

Accession 0001209191-20-055424

CIK 0001819790other

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 7:59 PM ET

Size

26.4 KB

Accession

0001209191-20-055424

Insider Transaction Report

Form 4
Period: 2020-10-20
Transactions
  • Purchase

    Common Stock

    2020-10-20$16.00/sh+168,750$2,700,0001,920,933 total
  • Conversion

    Common Stock

    2020-10-20+7,39650,547 total(indirect: By Trust)
  • Conversion

    Series A Preferred Stock

    2020-10-201,434,7900 total
    Common Stock (1,434,790 underlying)
  • Conversion

    Series B Preferred Stock

    2020-10-20245,9660 total
    Common Stock (245,966 underlying)
  • Conversion

    Series B Preferred Stock

    2020-10-207,3960 total(indirect: By Trust)
    Common Stock (7,396 underlying)
  • Conversion

    Common Stock

    2020-10-20+43,15143,151 total(indirect: By Trust)
  • Purchase

    Common Stock

    2020-10-20$16.00/sh+15,625$250,00066,172 total(indirect: By Trust)
  • Conversion

    Series C Preferred Stock

    2020-10-2071,4270 total
    Common Stock (71,427 underlying)
  • Conversion

    Common Stock

    2020-10-20+71,4271,752,183 total
  • Conversion

    Series A Preferred Stock

    2020-10-2043,1510 total(indirect: By Trust)
    Common Stock (43,151 underlying)
  • Conversion

    Common Stock

    2020-10-20+1,434,7901,434,790 total
  • Conversion

    Common Stock

    2020-10-20+245,9661,680,756 total
Footnotes (2)
  • [F1]Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into shares of the Issuer's common stock, par value $0.0001 per share, on a one-for-one basis. The shares of Preferred Stock had no expiration date.
  • [F2]The shares are held by Adam S. Horowitz Revocable Trust, of which Adam S. Horowitz is Trustee. Adam S. Horowitz is affiliated with Horowitz Limited Partnership VIII.

Issuer

Tarsus Pharmaceuticals, Inc.

CIK 0001819790

Entity typeother
IncorporatedCA

Related Parties

1
  • filerCIK 0001827839

Filing Metadata

Form type
4
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 7:59 PM ET
Size
26.4 KB